Clinical trial EFC15858/CARMEN-LC03
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel in Previously Treated metastatic Non-Squamous Non-Small Cell Lung Cancer patients with CEACAM5 positive tumors
Cancers | |
---|---|
Organ | Lung |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | Sanofi-Aventis |
EudraCT Identifier | 2019-001273-81 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04154956 |
Last update |